Home
Resources
Product Analysis
Acknowledgements
About
Home
References
Intended consumers
Intended consumers
Commercial
Products 51 to 60 of 150
Modify Display Properties
Biotech components
Business models
Country of production
Country of distribution
Intended consumer
Date added
Date last modified
Known funding amount
Funding types
Industry
Market status
Organization
Organization type(s)
Product categories
Production process
Source
Trading symbol
Value chain stage
Sort: Title (A-Z)
Date added (oldest-newest)
Date added (newest-oldest)
Date modified (oldest-newest)
Date modified (newest-oldest)
Title (A-Z)
Title (Z-A)
Organization (A-Z)
Organization (Z-A)
Deltazym® APS protease
by
BASF
Biotech components:
Molecule
Business models:
B2B
Country of production:
Switzerland
Country of distribution:
USA
+
Canada
+
Switzerland
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2019/05/15 15:47 (6 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Industrial
Market status:
More information needed
+
No longer on the market
Organization type(s):
Public Company
Product categories:
Fuel and Energy
Production process:
Open Release
Source:
Web search
Trading symbol:
BAS
(ETR)
Value chain stage:
Input
Detalzym GA L-E5 Glucoamylase
by
BASF
+
Verenium
Biotech components:
Enzyme
Business models:
B2B
Country of production:
Switzerland
Country of distribution:
Germany
+
USA
+
China
+
Japan
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/12/26 15:16 (6 years ago)
Known funding amount:
2,147,483,647 EUR
Funding types:
Shareholder Investment
Industry:
Industrial
Market status:
No longer on the market
Organization type(s):
Public Company
Product categories:
Fuel and Energy
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
BAS
(ETR)
Value chain stage:
Input
digitalDNA
by
Applied DNA Sciences
Biotech components:
Molecule
Business models:
B2C
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2019/01/30 12:02 (6 years ago)
Known funding amount:
19,800,000 USD
Funding types:
Shareholder Investment
Industry:
Security
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Forensic Tagging
Production process:
Closed Production
Source:
NASEM Database
Trading symbol:
APDN
(NASDAQ)
Value chain stage:
Platform
Disease-Resistent Cacao Plant
by
Innovative Genomics Institute
Biotech components:
Plant
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/10/08 14:51 (6 years ago)
Known funding amount:
N/A
Funding types:
Private Funding
+
University
Industry:
Food & Agriculture
Market status:
Early Stage Concept
Organization type(s):
Research Institution
Product categories:
Plant
Production process:
Open Release
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Finished Product
DNA Based Memory Device
by
Wyss Institute
+
Harvard University
Biotech components:
Bacteria
Business models:
B2C
Country of production:
USA
Country of distribution:
N/A
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
37,000,000 USD
Funding types:
University
+
Government
Industry:
Security
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Threat detection
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
N/A
Value chain stage:
Finished Product
DNA Nanorobots
by
Wyss Institute
+
Harvard University
Biotech components:
Enzyme
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
37,000,000 USD
Funding types:
University
+
Government
Industry:
Health
Market status:
Early Stage Concept
Organization type(s):
Private Company
Product categories:
Medical Treatment
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
N/A
Value chain stage:
Input
Dragon Silk
by
Kraig Biocraft Laboratories
Biotech components:
Animal
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
+
Vietnam
Intended consumer:
Commercial
+
Government
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
5,000,000 USD
Funding types:
Government
+
Shareholder Investment
Industry:
Industrial
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Fiber
Production process:
Closed Production
Source:
Scientist Magazine
Trading symbol:
KBLB
(OTCMKTS)
Value chain stage:
Input
Encapso
by
Solazyme
+
Encapso
Biotech components:
Plant
Business models:
B2C
Country of production:
USA
Country of distribution:
USA
+
Middle East
+
Canada
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2019/04/01 16:30 (6 years ago)
Known funding amount:
174,900,000 USD
Funding types:
Shareholder Investment
Industry:
Industrial
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Chemical
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
SZYM
(NASDAQ)
Value chain stage:
Finished Product
Engineered Insect Strains for Population/Disease Control
by
Oxitec
Biotech components:
Animal
Business models:
B2B
Country of production:
USA
Country of distribution:
Brazil
+
USA
+
India
+
Panama
+
Cayman Islands
Intended consumer:
Commercial
+
Government
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
26,132,305 GBP
Funding types:
Private Funding
Industry:
Health
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Medical Treatment
Production process:
Open Release
Source:
SynBio Database
Trading symbol:
N/A
Value chain stage:
Finished Product
Engineered Microbes for biomining, bioremediation, etc.
by
Universal Bio Mining
Biotech components:
Bacteria
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
N/A
Funding types:
N/A
Industry:
Industrial
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Resource Extraction
Production process:
Open Release
Source:
NASEM Database
Trading symbol:
N/A
Value chain stage:
Input
1
2
3
4
5
6
7
8
9
10
…
15
Login
or
register
to add and edit products
Future
Bioengineered
Products
Home
Resources
Product Analysis
Acknowledgements
About
